89 related articles for article (PubMed ID: 9697876)
1. Expression and regulation of c-kit receptor and response to stem cell factor in childhood malignant T-lymphoblastic cells.
Tomeczkowski J; Frick D; Schwinzer B; Wittner N; Ludwig WD; Reiter A; Welte K; Sykora KW
Leukemia; 1998 Aug; 12(8):1221-9. PubMed ID: 9697876
[TBL] [Abstract][Full Text] [Related]
2. C-kit receptors in childhood malignant lymphoblastic cells.
Sykora KW; Tomeczkowski J; Reiter A
Leuk Lymphoma; 1997 Apr; 25(3-4):201-16. PubMed ID: 9168431
[TBL] [Abstract][Full Text] [Related]
3. CD40 ligand upregulates expression of the IL-3 receptor and stimulates proliferation of B-lineage acute lymphoblastic leukemia cells in the presence of IL-3.
Zhou M; Gu L; Holden J; Yeager AM; Findley HW
Leukemia; 2000 Mar; 14(3):403-11. PubMed ID: 10720134
[TBL] [Abstract][Full Text] [Related]
4. Absence of c-kit receptor and absent proliferative response to stem cell factor in childhood Burkitt's lymphoma cells.
Tomeczkowski J; Beilken A; Frick D; Wieland B; König A; Falk MH; Reiter A; Welte K; Sykora KW
Blood; 1995 Aug; 86(4):1469-80. PubMed ID: 7543307
[TBL] [Abstract][Full Text] [Related]
5. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
[TBL] [Abstract][Full Text] [Related]
6. FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing upregulation of c-kit expression in cells of the mast cell line MC/9.
Ito F; Toyota N; Sakai H; Takahashi H; Iizuka H
Arch Dermatol Res; 1999 May; 291(5):275-83. PubMed ID: 10367710
[TBL] [Abstract][Full Text] [Related]
7. Stem cell factor suppresses apoptosis in neuroblastoma cell lines.
Timeus F; Crescenzio N; Valle P; Pistamiglio P; Piglione M; Garelli E; Ricotti E; Rocchi P; Strippoli P; Cordero di Montezemolo L; Madon E; Ramenghi U; Basso G
Exp Hematol; 1997 Nov; 25(12):1253-60. PubMed ID: 9357969
[TBL] [Abstract][Full Text] [Related]
8. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
Drexler HG
Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433
[TBL] [Abstract][Full Text] [Related]
9. Effects of stem cell factor on the growth and radiation survival of tumor cells.
Shui C; Khan WB; Leigh BR; Turner AM; Wilder RB; Knox SJ
Cancer Res; 1995 Aug; 55(15):3431-7. PubMed ID: 7542170
[TBL] [Abstract][Full Text] [Related]
10. Expression of stem cell factor and its receptor by human neuroblastoma cells and tumors.
Beck D; Gross N; Brognara CB; Perruisseau G
Blood; 1995 Oct; 86(8):3132-8. PubMed ID: 7579408
[TBL] [Abstract][Full Text] [Related]
11. Stem cell factor as a survival and growth factor in human normal and malignant hematopoiesis.
Hassan HT; Zander A
Acta Haematol; 1996; 95(3-4):257-62. PubMed ID: 8677752
[TBL] [Abstract][Full Text] [Related]
12. Stem cell factor and PIXY-321 in acute lymphoblastic leukemia: in vitro study on proliferative effects and apoptosis.
Petrucci MT; De Felice L; Ricciardi MR; Ariola C; Mascolo MG; Fenu S; Tafuri A
Cytokines Mol Ther; 1996 Dec; 2(4):225-30. PubMed ID: 9384708
[TBL] [Abstract][Full Text] [Related]
13. c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571.
Vitali R; Cesi V; Nicotra MR; McDowell HP; Donfrancesco A; Mannarino O; Natali PG; Raschellà G; Dominici C
Int J Cancer; 2003 Aug; 106(2):147-52. PubMed ID: 12800187
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta 1 interferes with the proliferation-inducing activity of stem cell factor in myelogenous leukemia blasts through functional down-regulation of the c-kit proto-oncogene product.
de Vos S; Brach MA; Asano Y; Ludwig WD; Bettelheim P; Gruss HJ; Herrmann F
Cancer Res; 1993 Aug; 53(15):3638-42. PubMed ID: 7687925
[TBL] [Abstract][Full Text] [Related]
15. Modulation of microglia by stem cell factor.
Zhang SC; Fedoroff S
J Neurosci Res; 1998 Jul; 53(1):29-37. PubMed ID: 9670990
[TBL] [Abstract][Full Text] [Related]
16. Growth stimulation of colorectal carcinoma cells via the c-kit receptor is inhibited by TGF-beta 1.
Bellone G; Silvestri S; Artusio E; Tibaudi D; Turletti A; Geuna M; Giachino C; Valente G; Emanuelli G; Rodeck U
J Cell Physiol; 1997 Jul; 172(1):1-11. PubMed ID: 9207920
[TBL] [Abstract][Full Text] [Related]
17. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
[TBL] [Abstract][Full Text] [Related]
18. Impact of the SCF signaling pathway on leukemia stem cell-mediated ATL initiation and progression in an HBZ transgenic mouse model.
Kuribayashi W; Takizawa K; Sugata K; Kuramitsu M; Momose H; Sasaki E; Hiradate Y; Furuhata K; Asada Y; Iwama A; Matsuoka M; Mizukami T; Hamaguchi I
Oncotarget; 2016 Aug; 7(32):51027-51043. PubMed ID: 27340921
[TBL] [Abstract][Full Text] [Related]
19. Haematopoietic action of flt3 ligand on cord blood-derived CD34-positive cells expressing different levels of flt3 or c-kit tyrosine kinase receptor: comparison with stem cell factor.
Sakabe H; Kimura T; Zeng Z; Minamiguchi H; Tsuda S; Yokota S; Hodohara K; Abe T; Lyman SD; Sonoda Y
Eur J Haematol; 1998 May; 60(5):297-306. PubMed ID: 9654159
[TBL] [Abstract][Full Text] [Related]
20. CS-1, a novel c-kithi+ acute myeloid leukemia cell line with dendritic cell differentiation capacity and absent immunogenicity.
Erben U; Thiel E; Bittroff-Leben A; Schoch C; Fichtner I; Dürkop H; Notter M
Int J Cancer; 2003 Jun; 105(2):232-40. PubMed ID: 12673685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]